Article Text
Editorial
Darwin and the survival of the fittest in modern interventional cardiology
Abstract
The diabetic patient requires a full armamentarium of proven and developing treatments in order to minimise periprocedural risk as well as improve long term outcome
- DES, drug eluting stents
- Gp, glycoprotein
- MACE, major adverse cardiac events
- MI, myocardial infarction
- PCI, percutaneous coronary intervention
- TLR, target lesion revascularisation
- diabetes mellitus
- glycoprotein IIb/IIIa
- percutaneous coronary intervention
- drug-eluting stent
Statistics from Altmetric.com
Footnotes
-
Published Online First 31 January 2006
-
Conflict of interest: none.